Technology
Health
Pharmaceutical

Cerecor

$3.52
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-1.95%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Cerecor and other stocks, options, ETFs, and crypto commission-free!

About CERC

Cerecor Inc. Common Stock, also called Cerecor, is a clinical stage biopharmaceutical company focuses in medical development. Read More It involves in the discovery, manufacture and commercialization of prescription for neurological and psychiatric disorders. It products include CERC-301, CERC-501, CERC-611, and CERC-406. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher and Solomon H. Snyder on January 31, 2011 and is headquartered in Baltimore, MD.

Employees
64
Headquarters
Rockville, Maryland
Founded
2011
Market Cap
151.03M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
86.04K
High Today
$3.66
Low Today
$3.39
Open Price
$3.61
Volume
48.33K
52 Week High
$7.65
52 Week Low
$2.71

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2015 IPO
US
North America

CERC Earnings

-$0.19
-$0.16
-$0.14
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.11 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.